These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18574212)

  • 1. Menstrual health and the metabolic syndrome in adolescents.
    Tfayli H; Arslanian S
    Ann N Y Acad Sci; 2008; 1135():85-94. PubMed ID: 18574212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.
    Huang J; Ni R; Chen X; Huang L; Mo Y; Yang D
    Reprod Biol Endocrinol; 2010 Nov; 8():142. PubMed ID: 21083920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
    Li L; Feng Q; Ye M; He Y; Yao A; Shi K
    J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.
    He Y; Tian J; Blizzard L; Oddy WH; Dwyer T; Bazzano LA; Hickey M; Harville EW; Venn AJ
    Hum Reprod; 2020 May; 35(5):1185-1198. PubMed ID: 32344436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.
    Glueck CJ; Morrison JA; Daniels S; Wang P; Stroop D
    J Pediatr; 2011 Aug; 159(2):308-13.e2. PubMed ID: 21362574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.
    Hart R; Doherty DA; Mori T; Huang RC; Norman RJ; Franks S; Sloboda D; Beilin L; Hickey M
    Fertil Steril; 2011 Jun; 95(7):2347-53, 2353.e1. PubMed ID: 21450287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midlife women's health consequences associated with polycystic ovary syndrome.
    Ali AT; Guidozzi F
    Climacteric; 2020 Apr; 23(2):116-122. PubMed ID: 31657237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
    Coviello AD; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
    Rahmanpour H; Jamal L; Mousavinasab SN; Esmailzadeh A; Azarkhish K
    J Pediatr Adolesc Gynecol; 2012 Jun; 25(3):208-12. PubMed ID: 22578482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.